Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDTA Eye Drops vs Abreva for Herpes Labialis
NCT04893577Phase 2Completed
- Sponsor
- University of Utah
- Start
- Jan 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethylenediaminetetraacetic acid in herpes labialis, sponsored by University of Utah. Started Jan 2022; status: completed.
02
Drugs
ethylenediaminetetraacetic acid
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT04893577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04893577.